CARBONIC ANHYDRASE INHIBITORS
Carbonic anhydrase inhibitors are a class of drugs that inhibit the activity of the enzyme carbonic anhydrase. They have diuretic properties and are used in the treatment of glaucoma, seizure and other neurological disorders, gastric and duodenal ulcers, and osteoporosis.
In glaucoma patients, carbonic anhydrase inhibitors lower intraocular pressure by decreasing the amount of fluid (aqueous humor) produced inside the eye.
Below is a list of common carbonic anhydrase inhibitors.
- Acetazolamide
- Brinzolamide
- Diclofenamide
- Dorzolamide
- Furosemide
- Mafenide
- Methazolamide
- Sultiame
- Topiramate
- Zonisamide
Additional Information about Carbonic Anhydrase Inhibitors
Pharmaceuticals for Glaucoma and Ocular Hypertension from Optometric Physicians of Washington (USA)
Pharmacodynamics of Diuretics from the University of Kentucky (USA)
Overview of Diuretics from the University of Washington (USA)
Related Topics
Return from Carbonic Anhydrase Inhibitors to Medical Terms Ca-Cz